Literature DB >> 21140375

Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-β.

Minggang Zhang1, Sheng Xu, Yanmei Han, Xuetao Cao.   

Abstract

UNLABELLED: The liver, a unique tolerogenic organ, is regarded as the site to trap and destroy aging erythrocytes and activated T cells. However, to date, the mechanisms for why the liver is tolerogenic and whether liver Kupffer cells (KC) are critical phagocytes for apoptotic cells (AC) contributing to the liver immunosuppression remain unclear. Here we report that KC is the main phagocyte for AC in the liver. Contact of AC inhibits proinflammatory cytokine but enhances anti-inflammatory cytokine production of KC in response to lipopolysaccharide (LPS) stimulation. Membrane-bound transforming growth factor (TGF)-β on AC is responsible for the increased production of interleukin (IL)-10 in KC through extracellular signal-regulated kinase (ERK) activation via the Smad3 pathway. Importantly, KC-derived IL-10 is critical for AC infusion-mediated protection of endotoxin-induced fulminant hepatitis through suppression of tumor necrosis factor (TNF)-α and nitric oxide (NO) production from KC and consequently attenuation of KC-mediated cytolysis of hepatocytes.
CONCLUSION: AC can be preferentially phagocytosed by KC in the liver, leading to attenuation of fulminant hepatitis through IL-10-mediated suppression of KC-derived inflammatory TNF-α and NO production. These findings demonstrate that priming of KC by AC may contribute to maintain liver immunosuppression, providing a new mechanistic explanation for how immune homeostasis is maintained in the liver.
Copyright © 2010 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21140375     DOI: 10.1002/hep.24029

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  32 in total

1.  Apoptotic cell administration enhances pancreatic islet engraftment by induction of regulatory T cells and tolerogenic dendritic cells.

Authors:  Cong Wu; Yi Zhang; Yingming Jiang; Quanxing Wang; Yao Long; Chunmei Wang; Xuetao Cao; Guoyou Chen
Journal:  Cell Mol Immunol       Date:  2013-07-22       Impact factor: 11.530

2.  Ag-specific CD4 T cells promote innate immune responses in liver ischemia reperfusion injury.

Authors:  Jianhua Rao; Feng Cheng; Shikun Yang; Yuan Zhai; Ling Lu
Journal:  Cell Mol Immunol       Date:  2018-06-15       Impact factor: 11.530

3.  Antigen-inexperienced memory CD8+ T cells: where they come from and why we need them.

Authors:  Jason T White; Eric W Cross; Ross M Kedl
Journal:  Nat Rev Immunol       Date:  2017-05-08       Impact factor: 53.106

Review 4.  Maxed out macs: physiologic cell clearance as a function of macrophage phagocytic capacity.

Authors:  Clive S Zent; Michael R Elliott
Journal:  FEBS J       Date:  2016-11-29       Impact factor: 5.542

5.  Sphingosine kinase 1 dependent protein kinase C-δ activation plays an important role in acute liver failure in mice.

Authors:  Yan-Chang Lei; Ling-Ling Yang; Wen Li; Pan Luo
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

Review 6.  Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.

Authors:  Elia Moreno-Cubero; Juan-Ramón Larrubia
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

Review 7.  O death where is thy sting? Immunologic tolerance to apoptotic self.

Authors:  Buvana Ravishankar; Tracy L McGaha
Journal:  Cell Mol Life Sci       Date:  2013-02-03       Impact factor: 9.261

8.  Foreign antigen-independent memory-phenotype CD4+ T cells: a new player in innate immunity?

Authors:  Ross M Kedl; Jason T White
Journal:  Nat Rev Immunol       Date:  2018-02-26       Impact factor: 53.106

9.  Immune tolerance in liver disease.

Authors:  Ian N Crispe
Journal:  Hepatology       Date:  2014-09-26       Impact factor: 17.425

10.  Inhibition of sphingosine kinase 1 ameliorates acute liver failure by reducing high-mobility group box 1 cytoplasmic translocation in liver cells.

Authors:  Yan-Chang Lei; Ling-Ling Yang; Wen Li; Pan Luo; Pei-Fen Zheng
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.